Boston Scientific Launches New Implantable Defibrillation Lead In Europe And Asia

RedOrbit

PARIS, Sept. 24, 2012 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received regulatory approval to market the RELIANCE® 4-FRONT(TM) lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.
 
Complete Story>>

< Back | Printer Friendly Page

In the News

06/25/2014

Western Maine Affiliate deploys AED

Oxford Federal Credit Union


06/14/2014

Senate Subcommittee Action on AED Program

Approval of more funds for rural AEDs

All News Stories »